991. Single Center, Exploratory, Open-label Prospective Study Using the Minimally Invasive LysinDAIR Procedure (Lysin Administration During an Arthroscopic DAIR Procedure) in Patients with Suspected Relapsing Chronic Coagulase-Negative Staphylococci (CNS) Prosthetic Hip Infection (PHI)

BACKGROUND: Exebacase, a recombinant staphylococcal lysin, has: (i) reported proof-of-concept data in Phase II in S. aureus bacteremia; (ii) demonstrated antibiofilm activity in vitro against S. epidermidis; and (iii) been used as salvage therapy in 4 patients with relapsing multidrug-resistant (MDR...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferry, Tristan, Conrad, Anne, Kolenda, Camille, Laurent, Frederic, Schmidt, Axel, Cassino, Cara, Lustig, Sebastien, Batailler, Cécile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752677/
http://dx.doi.org/10.1093/ofid/ofac492.833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752677/
http://dx.doi.org/10.1093/ofid/ofac492.833

Ejemplares similares